Viking Therapeutics is developing drugs for obesity and non-alcoholic fatty liver disease. The company has no revenue and may have none for several years as it works to get drug approval. Viking ...

That's what investors are hoping for from Viking Therapeutics (NASDAQ: VKTX), a young company seeking to establish itself in this highly competitive industry. Viking stock has been extraordinarily ...

A second analyst voices positive thoughts on Viking's new GLP-1 weight loss drug. Phase 3 clinical trial data on VK2735 arrives later this year, and phase 2 data on a GLP-1 pill could come out as ...

The Minnesota Vikings have exhausted all resources to piece together a championship-caliber roster for the upcoming season. They've invested approximately $300 million in 14 incoming free agents.

The media have not been so kind to Minnesota Vikings quarterback J.J. McCarthy with questions about his readiness to start. After recovering from his torn meniscus injury last year, McCarthy ...

Shares of Viking Therapeutics (NASDAQ: VKTX) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall Street analysts. Seedhouse doesn't beat around the bush: "Our thesis is ...

That includes Minnesota Vikings superstar wide receiver Justin Jefferson. He spoke with Bleacher Report recently to share his opinion. "I definitely thought that he should've been drafted in the ...

An investigation into Viking skeletons reveals a hidden story of violence, power, and the surprising differences between neighboring Viking societies. These bones came from all over Norway—from ...

The Minnesota Vikings took a stand with Jalen Nailor after the franchise drafted Tai Felton in the third round of the NFL Draft and then signed Silas Bolden as an undrafted free agent. In two ...

The most telling aspect of this Minnesota Vikings roster projection is how much more difficult it was to put together than in past years. That’s more of a reflection on their improved depth than ...